<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on OraSure Technologies from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated OraSure Technologies news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 00:47:44 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=OraSure+Technologies" rel="self" type="application/rss+xml" />

	
<item><title>OraSure and Roche in Worldwide Commercialization Agreement for Drugs of Abuse Assays</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030471&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533645093%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030471&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533645093%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Lab Medica:</description></item>
<item><title>New Members of PACHA-Presidential Advisory Council on AIDS</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018350&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018350&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525626824%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018350&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018350&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525626824%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>National AIDS Treatment Advocacy Project:</description></item>
<item><title>OraSure CEO Appointed to Presidential Advisory Council on HIV/AIDS</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008613&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008613&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521598898%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008613&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008613&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521598898%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954173&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954173&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2492544769%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954173&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954173&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2492544769%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Healthcare Sales &amp; Marketing Network:</description></item>
<item><title>OraSure Technologies and Roche sign commercialization agreement -...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940585&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940585&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485158078%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940585&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940585&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485158078%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>OraSure Technologies and Roche sign commercialization agreement</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940609&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940609&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485160849%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940609&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940609&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485160849%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>OraSure Technologies And Roche Diagnostics Sign Worldwide Commercialization Agreement For Fully Automated Oral Fluid Drugs Of Abuse Assays</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934347&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934347&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482177574%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934347&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934347&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482177574%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmaceutical Online:</description></item>
<item><title>OraSure inks deal with Roche Diagnostics</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932351&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932351&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481065558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932351&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932351&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481065558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Lehigh Valley Express-Times:</description></item>
<item><title>Market Report -- In Play (OSUR)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937563&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937563&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483568069%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937563&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937563&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483568069%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Briefing.com via MSN Money:</description></item>
<item><title>OraSure and Roche Sign Commercialization Agreement for Oral Fluid DOA Assays</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3936902&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3936902&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483237726%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3936902&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3936902&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483237726%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Clinical Lab Products:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Auto</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927460&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927460&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478918152%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927460&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927460&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478918152%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928976&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479421854%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928976&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479421854%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>I Stock Analyst:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927385&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927385&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478890361%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927385&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927385&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478890361%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via MSN Money:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3930787&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3930787&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480204086%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3930787&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3930787&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480204086%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927424&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927424&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478907571%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927424&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=OraSure%20Technologies&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927424&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478907571%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DMN Newswire:</description></item>
</channel></rss>